Literature DB >> 15713258

Properties of presynaptic P2X7-like receptors at the neuromuscular junction.

T S Moores1, B Hasdemir, L Vega-Riveroll, J Deuchars, S H Parson.   

Abstract

Adenosine triphosphate is released into the synaptic cleft of the neuromuscular junction during normal synaptic transmission, and in much greater quantities following injury and ischaemia. There is much data to suggest roles for presynaptic P2 receptors but little to demonstrate which specific receptor subunits are present. Here we show P2X7 receptor subunits on presynaptic motor nerve terminals from birth, but no evidence for P2X1, P2X2, P2X3, P2X4, P2X5 or P2X6 receptor subunits. Further, P2X receptor subunits are present as multimeric, membrane-inserted receptors. A selective agonist, 2'-3'-O-(4-benzoylbenzoyl)-adenosine 5'-triphosphate (BzATP: 100 microM), triggers vesicle release from motor nerve terminals, which is blocked by P2X7RS-specific concentrations of periodate oxidised ATP (OxATP: 100 microM) and brilliant blue G (BBG: 1 microM), but not by suramin (100 microM). Vesicle release is enhanced in the absence of extracellular divalent cations and occurs through activation of the ion channel and not any associated large pore, as we failed to label nerve terminals with large membrane-impermeant molecules after addition of BzATP. We conclude that a P2X7-like receptor is present at mouse motor nerve terminals, and that their activation promotes vesicle release.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713258     DOI: 10.1016/j.brainres.2004.12.001

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

Review 1.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

Review 2.  Purinergic modulation of synaptic signalling at the neuromuscular junction.

Authors:  Keith J Todd; Richard Robitaille
Journal:  Pflugers Arch       Date:  2006-04-08       Impact factor: 3.657

Review 3.  Neuronal P2X7 Receptor: Involvement in Neuronal Physiology and Pathology.

Authors:  M Teresa Miras-Portugal; Álvaro Sebastián-Serrano; Laura de Diego García; Miguel Díaz-Hernández
Journal:  J Neurosci       Date:  2017-07-26       Impact factor: 6.167

4.  P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons.

Authors:  Rachael Bartlett; Diane Ly; Neil R Cashman; Ronald Sluyter; Justin J Yerbury
Journal:  Purinergic Signal       Date:  2022-04-28       Impact factor: 3.765

5.  P2X7 receptors in neurohypophysial terminals: evidence for their role in arginine-vasopressin secretion.

Authors:  Adolfo E Cuadra; Edward E Custer; Elizabeth L Bosworth; José R Lemos
Journal:  J Cell Physiol       Date:  2014-03       Impact factor: 6.384

6.  Mechanism of P2X7 receptor-dependent enhancement of neuromuscular transmission in pannexin 1 knockout mice.

Authors:  Anna S Miteva; Alexander E Gaydukov; Valery I Shestopalov; Olga P Balezina
Journal:  Purinergic Signal       Date:  2018-10-25       Impact factor: 3.765

Review 7.  Purinergic signalling during development and ageing.

Authors:  Geoffrey Burnstock; Nicholas Dale
Journal:  Purinergic Signal       Date:  2015-05-20       Impact factor: 3.765

8.  P2 receptor-mediated modulation of neurotransmitter release-an update.

Authors:  Beáta Sperlágh; Attila Heinrich; Cecilia Csölle
Journal:  Purinergic Signal       Date:  2007-10-09       Impact factor: 3.765

9.  Dynamic remodelling of synapses can occur in the absence of the parent cell body.

Authors:  Natalia L Bettini; Thomas S Moores; Becki Baxter; Jim Deuchars; Simon H Parson
Journal:  BMC Neurosci       Date:  2007-09-26       Impact factor: 3.288

10.  P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Paola Fabbrizio; Savina Apolloni; Andrea Bianchi; Illari Salvatori; Cristiana Valle; Chiara Lanzuolo; Caterina Bendotti; Giovanni Nardo; Cinzia Volonté
Journal:  Brain Pathol       Date:  2019-08-18       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.